Free
Perioperative Medicine  |   February 2017
Sevoflurane Exposure during the Critical Period Affects Synaptic Transmission and Mitochondrial Respiration but Not Long-term Behavior in Mice
Author Notes
  • From the Department of Anesthesia and Pain Medicine, Chungnam National University, Daejeon, South Korea (W.C., S.L., S.Y., S.P., Y.H.K., S.H.Y., Y.S.S., W.H.L., Y.K.); Departments of Biochemistry (M.J.R., J.Y.H., G.R.K.) and Medical Science (J.Y.H., X.J.), Chungnam National University School of Medicine, Daejeon, South Korea; and Departments of Biological Sciences (H.P.) and Biomedical Sciences (Y.K.), Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
  • This article is featured in “This Month in Anesthesiology,” page 1A.
    This article is featured in “This Month in Anesthesiology,” page 1A.×
  • Submitted for publication March 3, 2016. Accepted for publication October 28, 2016.
    Submitted for publication March 3, 2016. Accepted for publication October 28, 2016.×
  • Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are available in both the HTML and PDF versions of this article. Links to the digital files are provided in the HTML text of this article on the Journal’s Web site (www.anesthesiology.org).
    Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are available in both the HTML and PDF versions of this article. Links to the digital files are provided in the HTML text of this article on the Journal’s Web site (www.anesthesiology.org).×
  • W.C., M.J.R., and J.Y.H. contributed equally to this article.
    W.C., M.J.R., and J.Y.H. contributed equally to this article.×
  • Address correspondence to Dr. Ko: Department of Anesthesiology and Pain Medicine, Chungnam National University, School of Medicine, Daejeon 301-721, South Korea. annn8432@gmail.com. Information on purchasing reprints may be found at www.anesthesiology.org or on the masthead page at the beginning of this issue. Anesthesiology’s articles are made freely accessible to all readers, for personal use only, 6 months from the cover date of the issue.
Article Information
Perioperative Medicine / Basic Science / Pharmacology
Perioperative Medicine   |   February 2017
Sevoflurane Exposure during the Critical Period Affects Synaptic Transmission and Mitochondrial Respiration but Not Long-term Behavior in Mice
Anesthesiology 2 2017, Vol.126, 288-299. doi:10.1097/ALN.0000000000001470
Anesthesiology 2 2017, Vol.126, 288-299. doi:10.1097/ALN.0000000000001470
Abstract

Background: Anesthesia during the synaptogenic period induces dendritic spine formation, which may affect neurodevelopment. The authors, therefore, evaluated whether changes in synaptic transmission after dendritic spine formation induced by sevoflurane were associated with long-term behavioral changes. The effects of sevoflurane on mitochondrial function were also assessed to further understand the mechanism behind spinogenesis.

Methods: Postnatal day 16 to 17 mice were exposed to sevoflurane (2.5% for 2 h), and synaptic transmission was measured in the medial prefrontal cortex 6 h or 5 days later. The expression of postsynaptic proteins and mitochondrial function were measured after anesthesia. Long-term behavioral changes were assessed in adult mice.

Results: Sevoflurane increased the expression of excitatory postsynaptic proteins in male and female mice (n = 3 to 5 per group). Sevoflurane exposure in male mice transiently increased miniature excitatory postsynaptic current frequency (control: 8.53 ± 2.87; sevoflurane: 11.09 ± 2.58) but decreased miniature inhibitory postsynaptic current frequency (control: 10.18 ± 4.66; sevoflurane: 6.88 ± 2.15). Unexpectedly, sevoflurane increased miniature inhibitory postsynaptic current frequency (control: 1.81 ± 1.11; sevoflurane: 3.56 ± 1.74) in female mice (neurons, n = 10 to 21 per group). Sevoflurane also increased mitochondrial respiration in male mice (n = 5 to 8 per group). However, such changes from anesthesia during the critical period did not induce long-term behavioral consequences. Values are presented as mean ± SD.

Conclusions: Sevoflurane exposure during the critical period induces mitochondrial hyperactivity and transient imbalance of excitatory/inhibitory synaptic transmission, without long-lasting behavioral consequences. Further studies are needed to confirm sexual differences and to define the role of mitochondrial activity during anesthesia-induced spine formation.

What We Already Know about This Topic
  • Exposure of the brain to anesthetics at a time of development wherein neurons are not vulnerable to apoptosis (approximately postnatal day [PND] 15 to PND17) leads to increased dendritic spine and synapse formation. The impact of these changes on long-term neurobehavioral function is not known.

  • Male and female mice were exposed to 2.5% sevoflurane for 2 h at PND16 to PND17. Electrophysiologic function was evaluated within 6-h exposure and 5 days after exposure. Behavioral function was assessed at 2 to 3 months of age.

What This Article Tells Us That Is New
  • Sevoflurane transiently increased excitatory transmission at 6 h post exposure in male but not in female mice. By contrast, inhibitory transmission was decreased in male mice but increased in female mice at 6 h post exposure.

  • No changes in behavioral function were observed.

  • The results suggest that the transient changes induced by sevoflurane in excitatory and inhibitory transmission do not impact long-term cognitive function.

MANY animal studies have reported that postnatal exposure to anesthetics may be neurotoxic.1–10  Retrospective clinical studies assessing the neurotoxic effects of anesthetics have reported inconsistent outcomes,11–13  and several randomized controlled trials are being performed.14–16  Two trials have recently reported that brief exposures to general anesthesia during infancy do not increase the risk of adverse neurodevelopmental outcome.14,16  Although reassuring, exposure to anesthetics may have negative effects at older ages, as may relatively longer or multiple exposure to anesthetics during neurodevelopment.
Importantly, rodent studies have reported different neurotoxic consequences from general anesthesia in a neurodevelopmental stage-dependent manner. Most rodent studies have focused on the first postnatal week, showing widespread neurodegeneration after exposure to general anesthetics. However, recent studies focusing on older rodents have reported that anesthesia during the critical synaptogenic period induces dendritic spine formation rather than widespread neuroapoptosis.6–10 
Dendritic spines are postsynaptic actin-based protrusions that regulate the structure, function, and plasticity of excitatory synapses. Dendritic spine abnormalities and changes in excitatory/inhibitory synaptic transmission during the critical synaptogenic period may be associated with neurodevelopmental disorders, including intellectual disability and autism.17,18  Since anesthetics induce dendritic spine formation during the critical synaptogenic period, this may explain results indicating an association between general anesthesia and neurodevelopmental disorders.19–21  However, the effects of these newly developed spines on synaptic transmission and cognitive function have not yet been extensively studied. In addition, the mechanism behind anesthesia-induced spinogenesis during the critical period has not yet been determined. Mitochondrial energy may be essential for supporting the high metabolic requirements of spine formation after general anesthesia.22  For example, isoflurane has been shown to attenuate ischemic–reperfusion stress by enhancing mitochondrial respiratory chain activity.23  Because the mechanism by which anesthesia induces neuroapoptosis in rodents during the first postnatal week includes mitochondrial dysfunction, the effects of anesthetics on mitochondrial function may depend on the neurodevelopmental stage. Anesthesia may, therefore, induce widespread neurodegeneration via mitochondrial dysfunction or dendritic spine synthesis via mitochondrial activation.
In order to verify the possibility that early anesthesia may lead to changes in synaptic transmission after dendritic spine formation and induce long-term neurodevelopmental behavior impairments, this study was designed to evaluate the effects of sevoflurane, one of the most widely used anesthetic agents in pediatric patients, in postnatal day (PND) 16 to 17 mice. Also, to better understand the mechanism underlying anesthesia-induced spinogenesis, the effects of sevoflurane exposure on mitochondrial function were analyzed. This study found that exposure to sevoflurane (2.5% for 2 h) during the critical synaptogenic period alters mitochondrial function and induces a transient imbalance of excitatory/inhibitory synaptic transmission sex dependently but does not induce long-term behavioral changes.
Materials and Methods
Animals
C57BL/6J mice were maintained according to the Animal Research Requirements of the Korea Advanced Institute of Science and Technology, Daejeon, South Korea. All experiments were approved by the Committees on Animal Research at Korea Advanced Institute of Science and Technology (KA2010-18) and Chungnam National University Hospital, Daejeon, South Korea (CNUH-014-A0009). Mice were housed in a room maintained at 22°C, with a 12-h light/12-h dark cycle, and fed ad libitum. The mice were weaned at 3 weeks of age and housed in separate cages in groups of three to five.
Anesthesia
Male PND 16 to 17 mice were randomly divided into two groups: an anesthesia group and a control group. Each mouse in the anesthesia group was placed in a 1-l plastic chamber and exposed to a constant flow of fresh gas (fraction of inspired oxygen [Fio2] 1.0, 5 l/min) containing 2.5% sevoflurane for 2 h. Full recovery was confirmed 30 min later, while 100% oxygen was continuously provided. Fresh air was warmed to 36°C and humidified (MR730; Fisher & Paykel Healthcare, New Zealand). Mice in the control group were treated identically but without sevoflurane. Carbon dioxide and sevoflurane were monitored using an S/5 compact anesthetic monitor and an e-CAiO gas analyzer module (Datex-Ohmeda, Finland), respectively.
Arterial Blood Gas Analysis
After 2 h of sevoflurane exposure, the mice were decapitated and trunk blood was collected. Blood gas was analyzed using iSTAT (Abbott, United Kingdom). The results of blood gas analysis are summarized in table 1.
Table 1.
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia×
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Table 1.
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia×
×
Western Blotting
Protein samples were obtained 0, 3, 6, and 9 h after sevoflurane or oxygen exposure. For ethical reasons, mice were exposed to 3% sevoflurane for 5 to 10 min before sampling. The mice were euthanized by decapitation, their brains were removed, and the whole cerebral cortex region was homogenized with a tissue grinder in radio immunoprecipitation assay lysis buffer (ELPIS-BIOTECH, Korea, 100 mM Tris–hydrochloride [pH 8.5], 200 mM NaCl, 5 mM EDTA, and 0.2% sodium dodecyl sulfate), containing a phosphatase and protease inhibitor cocktail, followed by centrifugation of the homogenized tissue samples at 15,000g for 20 min at 4°C. The supernatants were collected, and their protein concentrations were measured using the Bradford assay (Bio-Rad, USA). Samples (20 µg) were electrophoresed on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (ELPIS- BIOTECH), and the separated proteins were transferred at 200 mA for 2 h onto nitrocellulose membranes (pore size, 0.2 µm; Amersham Protran®, GE Healthcare, United Kingdom). The membranes were blocked for 1 h with Tris-buffered saline with Tween 20 (made of 10 mM Tris–hydrochloride [pH 7.6], 150 mM NaCl, and 0.1% Tween 20), containing 3% bovine serum albumin (BSA), followed by incubation with primary antibodies and the appropriate secondary antibodies coupled to horseradish peroxidase. Specific antibody-labeled proteins were detected using the enhanced chemiluminescence system (WEST-ZOL plus; iNtRON BioTechnology, Korea). Primary antibodies included antibodies to postsynaptic density 90 (PSD95; Neuromab, USA), NDUFB8 (a mitochondrial complex I subunit; Santa Cruz Biotechnology, USA), poly (adenosine diphosphate [ADP]-ribose) polymerase (Santa Cruz Biotechnology), caspase 3 (Cell Signaling Technology, USA), and actin (Santa Cruz Biotechnology). Antibodies against GluA1 (1193) and GluA2 (1195) have been described previously.24 
Behavioral Tests
All behavioral tests were performed as previously described,3,25,26  using age-matched adult male mice, aged 2 to 3 months, during the active (night) period of the circadian cycle. Behavior tests were performed with two cohorts of mice. Light-dark box test, open field test, three-chamber test, and fear test were performed with the first cohort. Elevated plus maze and novel object recognition tests were performed with the second cohort. All procedures were recorded and later analyzed manually or with a tracking software (Ethovision XT; Noldus Information Technology, The Netherlands).
Light-dark Box
Mice were placed in the center of a lighted compartment (800 to 900 lux), facing away from the dark compartment. Total duration spent in the light chamber (%) was measured for 10 min.
Elevated Plus Maze
The elevated plus maze consisted of two open arms, two closed arms, and a center zone elevated to a height of 50 cm above the floor. Mice were placed in the center of the maze facing an open arm and were allowed to explore the maze for 10 min.
Open Field Test
Mice were placed in the center of an open field box, measuring 40 × 40 × 40 cm. General activity was analyzed for 1 h, with the center zone defined as the area greater than or equal to 10 cm from each wall.
Three-chamber Test
A previously described three-chamber apparatus was used in which each side chamber contained a plastic cage. The experiment consisted of three sessions, each lasting 10 min. During the first session, the mice were confined to the center chamber; during the second session, the mice were allowed to freely explore all three chambers. After these two habituation sessions, a novel object, consisting of a blue cube measuring 3.0 × 3.0 × 4.0 cm, and a novel stranger, consisting of a mouse of the same age and sex, were placed inside each side chamber cage. The subject mouse was allowed to freely explore the apparatus for 10 min. The positions of the object and stranger were alternated between tests to prevent side preference. Preference index (PI) was calculated by using the time spent in each chamber (Mo, time spent in the mouse chamber; Ob, time spent in the object chamber): PI (%) = (Mo − Ob)/(Mo + Ob) × 100.
Grooming
Mice were placed in the center of a home cage without bedding for 20 min. Cages were changed for each experiment. Grooming was manually measured for 10 min after a 10-min habituation period.
Digging
Digging was defined as the coordinate movement of two fore- or hind legs to displace bedding. Mice were placed in a standard home cage with 5 cm of wood-chip bedding and recorded.
Novel Object Recognition Test
Mice were habituated to the open field box for 30 min for two consecutive days. On the third day (sample phase), the mice were placed in the open field box and allowed to explore two identical objects for 10 min. Four hours later (test phase), one of the objects was replaced with a novel object, and the mice were again allowed to explore each object freely for 10 min. Object exploration time was defined as the time each mouse’s nose was within 2 cm of the object. Object replacement was alternated to prevent side preference. PI was calculated with the exploration time (new, exploration time for the novel object; old, exploration time for the previous object): PI (%) = (new − old)/(new + old) × 100.
Fear Test
Fear tests were performed in a conditioning chamber containing a metal grid floor (Coulbourn Instruments, USA) within a sound-attenuating chamber. The conditioned stimulus (CS) was a 20-s, 3-kHz, 80-dB tone, and the unconditioned stimulus was a 1-mA, 1-s electric shock delivered at the end of the CS. After a 5-min habituation period, mice received a CS and unconditioned stimulus three times (60-s interval). Twenty-four hours later, the mice were placed in the same chamber for 5 min (contextual fear test). After an additional 24 h, the mice were placed in a different context (mint-scented, white circular plastic chamber) and exposed to the 3-kHz, 80-dB tone for 3 min after a 5-min habituation period (cue test). Freezing behavior was automatically measured with Freezeframe software (Coulbourn Instruments).
Electrophysiology
Whole-cell patch-clamp recordings of layer II and III pyramidal neurons in the medial prefrontal cortex (mPFC) were performed 6 h or 5 days after exposure to sevoflurane or oxygen, as described previously.25  Coronal slices of the mPFC (300 µm) were prepared using a VT1200S vibratome (Leica, Switzerland) in an ice-cold dissection buffer (212 mM sucrose, 25 mM NaHCO3, 5 mM KCl, 1.25 mM NaH2PO4, 10 mM d-glucose, 2 mM sodium pyruvate, 1.2 mM sodium ascorbate, 3.5 mM MgCl2, and 0.5 mM CaCl2) continuously aerated with 95% O2/5% CO2. The slices were transferred to a chamber filled with artificial cerebrospinal fluid (125 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4, 10 mM d-glucose, 1.3 mM MgCl2, and 2.5 mM CaCl2), aerated with 95% O2/5% CO2, and warmed to 32°C for 30 min for recovery. Glass capillaries were filled with an internal solution (117 mM CsMeSO4, 10 mM tetraethylammonium chloride, 8 mM NaCl, 10 mM HEPES, 5 mM QX-314-Cl, 4 mM Mg-adenosine triphosphate [ATP], 0.3 mM Na-guanosine triphosphate, and 10 mM EGTA for miniature excitatory postsynaptic current [mEPSC] recordings; 115 mM CsCl, 10 mM tetraethylammonium chloride, 8 mM NaCl, 10 mM HEPES, 5 mM QX-314-Cl, 4 mM Mg-ATP, 0.3 mM Na-guanosine triphosphate, and 10 mM EGTA for miniature inhibitory postsynaptic current [mIPSC] recordings), and recordings were made using a MultiClamp 700B amplifier (Molecular Devices, USA) under visual control (BX50WI; Olympus, Japan). Data were acquired with Clampex 9.2 (Molecular Devices) and analyzed using Clampfit 9 (Molecular Devices).
Mitochondrial Oxygen Consumption Rate
Mitochondria were isolated from the cerebral cortex as described previously.27,28  Briefly, the cerebral cortex was homogenized in a mitochondrial isolation buffer (70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM EGTA, and 0.5% [w/v] fatty acid–free BSA [pH 7.2]) with a Teflon-glass homogenizer (Thomas Scientific, USA). After centrifuging at 600g for 10 min at 4°C and at 17,000g for 10 min at 4°C, the mitochondrial fraction was resuspended in mitochondrial isolation buffer. Protein concentration was measured with the Bradford assay (Bio-Rad). Aliquots containing 20 µg protein were each diluted with 50 µl mitochondrial assay solution (70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA, 0.2% [w/v] fatty acid–free BSA, 10 mM succinate, and 2 μM rotenone [pH 7.2]) and seeded in an XF-24 plate (Seahorse Bioscience, USA). The plates were centrifuged at 2,000g for 20 min at 4°C using a swinging bucket microplate adaptor (Effendorf, Germany). After adding 450 µl mitochondrial assay buffer, the XF-24 plate (Seahorse Bioscience) was maintained at 37°C for 8 to 10 min and then transferred to the Seahorse XF-24 extracellular flux analyzer (Seahorse Bioscience). Mitochondrial function was determined by measuring the oxygen consumption rate (OCR). Real-time readings were taken for five stages: stage I, basal level; stage II, addition of ADP to measure ATP production; stage III, addition of oligomycin, a mitochondrial oxidative phosphorylation (OXPHOS) complex 5 inhibitor, to measure protein leakage; stage IV, addition of the mitochondrial OXPHOS complex 4 inhibitor carbonyl cyanide m-chlorophenyl hydrazine to measure maximal respiration; and stage V, addition of the mitochondrial OXPHOS complex 3 inhibitor antimycin A to measure nonmitochondrial respiration. OCR was automatically calculated and recorded using the Seahorse XF-24 software (Seahorse Bioscience).
Statistical Analysis
Behavioral studies were performed and analyzed blindly. Since brain slices, Western blot samples, and mitochondrial samples of both groups were prepared simultaneously, these were prepared nonblindly in order to avoid confusion. However, the experiments were all performed and analyzed in a blinded manner. Sample size for tests was based on previous experiences or as previously described.3,25,29  There are no lost or missing data in our study. All statistical analyses were performed using R statistical software (3.1.2: R Core Team, Austria) and GraphPad Prism 5 software (GraphPad Software, USA). All continuous variables were tested to determine whether they met conditions of normality and homogeneity of variance. Student’s t tests were performed when both conditions were met; Welch t test was performed when homogeneity of variance was unmet, and the Kruskal–Wallis test was performed if normality was unmet. Repeatedly measured data were analyzed via mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. P < 0.05 was considered statistically significant. Bonferroni post hoc testing was used for multiple comparisons. See the table (Supplemental Digital Content 1, http://links.lww.com/ALN/B349) for summary of statistics.
Results
Sevoflurane Exposure Induces a Transient Imbalance of Excitatory/Inhibitory Synaptic Transmission in Male Mice
Although several studies have shown that brief to moderate exposure to sevoflurane induces dendritic spine formation,6–10  the effects of spinogenesis on synaptic transmission had not been analyzed. We, therefore, evaluated the acute and long-term effects of sevoflurane on synaptic transmission by measuring mEPSCs/mIPSCs of layer II and III pyramidal neurons in the mPFC. Brain slices of the mPFC were prepared 6 h or 5 days after sevoflurane exposure. Although there was no change in mEPSC amplitude, its frequency was significantly increased 6 h after exposure to anesthesia (fig. 1, A and B), indicating that sevoflurane induces functional dendritic spines, leading to increased excitatory synaptic transmission. Unexpectedly, the frequency of mIPSCs was significantly decreased 6 h after sevoflurane exposure (fig. 1, C and D). However, recordings of mEPSCs/mIPSCs 5 days after sevoflurane exposure were comparable, indicating that sevoflurane does not have long-term effects on synaptic transmission (fig. 1, E to H).
Fig. 1.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
Fig. 1.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
×
Sevoflurane Exposure Increases the Expression of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Subunit GluA2
Expression levels of PSD-95, a scaffold protein abundantly expressed in the postsynapse (fig. 2, A to E), and subunits of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor, an ionotropic transmembrane glutamate receptor (fig. 2, A to D, F, and G), were analyzed over time with protein samples of the whole cerebral cortex after exposure to sevoflurane. The expression level of subunit GluA2 was significantly increased 3 and 6 h after sevoflurane exposure.
Fig. 2.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Fig. 2.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
×
Anesthetic agents have been reported to induce widespread neuronal cell death during the prenatal and immediate postnatal stages but not during later stages of development. Exposure of PND 16 to 17 mice to sevoflurane did not increase the expression of cell death markers such as cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase (fig. 2, A to D).
Sevoflurane-induced Transient Imbalance of Excitatory/Inhibitory Synaptic Transmission during the Critical Period Does Not Affect Adult Male Mouse Behavior
Changes in dendritic spines and imbalances in excitatory/inhibitory synaptic transmission during the critical period have been shown to be associated with neurodevelopmental disorders. A series of experiments were, therefore, performed to evaluate the long-term behavioral effects of sevoflurane exposure. Sevoflurane-treated mice showed normal activity and anxiety levels in the open field test (fig. 3, A and B). Their anxiety level was comparable to that of the control group in the light-dark box and elevated plus maze tests (fig. 3, C and D). The sociability level, which has been shown to decrease in autism model mice, was also normal in the three-chamber test (fig. 3, E to G). Learning and memory were normal in the novel object recognition and fear chamber tests (fig. 3, H to K).
Fig. 3.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
Fig. 3.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
×
Sevoflurane during the Critical Period Affects Mitochondrial Function in a Time-dependent Manner in Male Mice
Although the mechanism underlying neuronal cell death during the prenatal and immediate postnatal periods remains unclear, anesthesia-induced mitochondrial dysfunction and consequent overproduction of reactive oxygen species have been reported to play important roles. However, the effects of anesthetic agents on mitochondrial function at the age of PND 16 and 17 have not been determined. Because neuronal cell death does not occur during this period, mitochondrial function may be less affected. As dendritic mitochondria were shown to be deeply involved with the process of dendritic spine formation,22  mitochondrial function was evaluated by measuring OCR after sevoflurane exposure (fig. 4, A to H). OCR was significantly reduced immediately after anesthesia but recovered 3 h later (fig. 4, A to D). Interestingly, 3 h after sevoflurane exposure, OCR was significantly increased by treatment with ADP (stage II; fig. 4, C and D). Even basal OCR was significantly increased 9 h after anesthesia (fig. 4, G and H). Time-dependent changes in mitochondrial activity were also analyzed by measuring the expression level of NDUFB8, a subunit of OXPHOS complex 1. Although anesthesia induced a similar trend of expression level changes after anesthesia, these changes were not statistically significant (fig. 4, I and J).
Fig. 4.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
Fig. 4.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
×
Sevoflurane Exposure in Female Mice Induces Different Electrophysiologic Changes That Do Not Affect Adult Female Behavior
Male mice have been suggested to be more sensitive to the neurotoxic effects of anesthetics.30  Also, interpretation of behavioral studies can be complex in female mice due to hormonal factors.31  However, in order to make a general conclusion about how sevoflurane affects neurodevelopment, female mice were also analyzed after an identical sevoflurane exposure. Unexpectedly, unlike male mice, there was no increase in mEPSC frequency 6 h after sevoflurane exposure (fig. 5, A and B). However, whole cerebral cortex samples of female mice show identical increases of excitatory synaptic protein expression 6 h after sevoflurane exposure (fig. 5, C and D). Most interestingly, the frequency of mIPSC was significantly increased 6 h after sevoflurane exposure (fig. 5, E and F), opposite to that of male mice that displayed a significant decrease in mIPSC frequency (fig. 1B). Such changes in synaptic transmission did not affect adult female behavior in the open field test, three-chamber test, and fear chamber test (fig. 5, G to L).
Fig. 5.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Fig. 5.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
×
Discussion
While initial animal studies focused on the early postnatal brain, many studies now focus on a later stage, which may represent the critical period in humans.6–10  These studies suggest that anesthetic agents induce dendritic spine formation, not widespread neurodegeneration. However, most of these studies focused on structural and morphologic changes in dendrites. To date, few studies have evaluated the function and long-term behavioral consequences of such spinogenesis.
Dendritic spines are actin-based protrusions on which most excitatory synapses form.32  Dendritic spines can be distinguished from filopodia, another type of dendritic protrusion that does not form excitatory synapses, by their characteristic morphology. Most studies evaluating dendritic changes after exposure to anesthetics have, therefore, assessed dendritic spines morphologically.7,10  Electron microscopy showed the presence of excitatory synapses in propofol-induced dendritic spines, suggesting that these newly formed spines were functional.7  Although functionality has been assessed indirectly through calcium imaging,9  overall changes in excitatory synaptic transmission resulting from anesthesia-induced spinogenesis have not been determined. By analyzing the mEPSCs in layer II and III pyramidal neurons in the mPFC, we found that excitatory synaptic transmission significantly increased 6 h after exposure of PND 16 to 17 mice to sevoflurane in male mice. This increase was not long-lasting as synaptic transmission had normalized when analyzed 5 days after exposure to anesthesia. This finding is in good agreement with a recent study, which found no long-term changes in synaptic transmission 3 months after exposure to sevoflurane for 30 min.8  Unexpectedly, female mice did not show increased excitatory synaptic transmission. However, the expression level of synaptic proteins was also significantly increased after sevoflurane exposure in female mice. Sevoflurane exposure also increased the expression level of PSD-95 in the thalamus, a region vulnerable to anesthesia-induced neurodegeneration in both male and female mice (Supplemental Digital Content 2, http://links.lww.com/ALN/B350). Additional female mice studies focusing on different cell layers of the cortex or different brain regions are needed to explain the discrepancy between electrophysiology and Western blot results.
Inhibitory synapses have been known to exist mostly on the dendritic shaft. However, recent studies now show that 30% inhibitory synapses reside on dendritic spines in adult mice.33  Thus, in order to evaluate the effects of early anesthesia on synaptic transmission, we also analyzed changes in mIPSCs. Our results show that inhibitory synaptic transmission is also transiently altered after sevoflurane exposure. Even more interesting was the fact that such changes were observed in the opposite direction between male and female mice (fig. 1, C and D and fig. 5, E and F). Previous studies have shown that sexually dimorphic gene expression and gonadal steroid hormones promote sex differences during neurodevelopment.34  Such differences have been suggested to be involved with the sex-dependent incidence of neurodevelopmental disorders.35  Although additional studies are needed to confirm sexual differences of anesthetic neurotoxicity, it is possible that such sex-dependent differences in neurodevelopment may also affect the consequences of anesthetic neurotoxicity.
Although it is reassuring that changes in excitatory/inhibitory synaptic transmission are not long lasting, even transient changes during the critical period may affect neurodevelopment.18  Several clinical studies have found that early exposure to anesthetic agents may influence neurodevelopment.21,36  In contrast, a recent animal study found that a 30-min exposure to sevoflurane did not induce deficiencies in memory.8  Our results show that a 2-h sevoflurane exposure does not induce long-term behavioral changes in general activity, anxiety, sociability, learning, and memory. However, as clinical studies have suggested that multiple exposures to anesthesia may have a greater effect on development, studies assessing the consequences of multiple exposures are needed.19,37,38 
Studies have also focused on the mechanisms underlying the inadvertent effects of general anesthetics in the developing brain. Although still unclear, mitochondrial respiratory chain dysfunction and the increase in reactive oxygen species resulting from dysfunctions in mitochondrial complexes I and III may play important roles in the widespread neuroapoptosis that occurs when rodents are exposed to anesthesia during the first postnatal week.39,40  Anesthesia-induced neurodegeneration may, therefore, be prevented by mitochondrial protection.41,42  However, anesthetics have also been shown to increase mitochondrial complex activity. For example, exposure to propofol has been shown to increase mitochondrial complex I activity, leading to cardioprotection,43  and exposure to isoflurane protects cardiac muscle from ischemia-induced damage by enhancing mitochondrial complex activity.23  To date, no study has assessed the effects of anesthetics on mitochondrial function in PND 16 to 17 mice, a period when anesthesia has been shown to induce dendritic spine formation. Dendritic mitochondria play a vital role in spinogenesis, with mitochondrial fission facilitating the dendritic localization of mitochondria.22,44  Fissional changes in mitochondria increase the number of mitochondria, satisfying the high energy demand during spinogenesis. Anesthetics may actually increase dendritic mitochondrial activity, thus allowing spinogenesis to occur. Our measurements of mitochondrial OCRs show that exposure to sevoflurane during the critical period induced time-dependent changes in mitochondrial activity in male mice. Mitochondria are hypoactive directly after anesthesia but become significantly more active within hours. Further studies are required to determine the precise role of mitochondrial activity after sevoflurane exposure during the critical synaptogenic period.
This study has several limitations, including the lack of respiratory control during sevoflurane exposure. Although we were able to avoid hypoxia with an Fio2 of 1.0, blood gas analysis showed a significant increase in carbon dioxide and a reduction in pH. Anesthesia-induced alterations of systemic homeostasis in small rodents have been shown to cause long-lasting cognitive dysfunctions.45  Although our results are in agreement with studies showing normal physiologic parameters during anesthesia,6,8  with no increases in neuronal cell death and cognitive impairment, sevoflurane-induced loss of systemic homeostasis may have affected other parameters, such as mitochondrial activity. Another limiting factor is the use a high Fio2 (1.0) during sevoflurane exposure. Since high concentrations of oxygen itself can be toxic,46  they may have affected the changes during anesthesia.
In conclusion, this study shows that sevoflurane exposure during the critical period induces mitochondrial hyperactivity and an acute, short-term imbalance of excitatory/inhibitory synaptic transmission without long-lasting behavioral consequences. Further studies are needed to confirm the sexual differences and to define the role of mitochondrial activity changes during anesthesia-induced spine formation.
Research Support
Supported by the National Research Foundation of Korea (grant nos. NRF-2015R1C1A1A01054659, 2014R1A1A1037655, and HRF-2014R1A2A1A11051231; Daejeon, Korea) and the research fund of Chungnam National University (Daejeon, Korea).
Competing Interests
The authors declare no competing interests.
References
Jevtovic-Todorovic, V, Hartman, RE, Izumi, Y, Benshoff, ND, Dikranian, K, Zorumski, CF, Olney, JW, Wozniak, DF Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.. J Neurosci. (2003). 23 876–82 [PubMed]
Satomoto, M, Satoh, Y, Terui, K, Miyao, H, Takishima, K, Ito, M, Imaki, J Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice.. Anesthesiology. (2009). 110 628–37 [Article] [PubMed]
Chung, W, Park, S, Hong, J, Park, S, Lee, S, Heo, J, Kim, D, Ko, Y Sevoflurane exposure during the neonatal period induces long-term memory impairment but not autism-like behaviors.. Paediatr Anaesth. (2015). 25 1033–45 [Article] [PubMed]
Creeley, C, Dikranian, K, Dissen, G, Martin, L, Olney, J, Brambrink, A Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain.. Br J Anaesth. (2013). 110Suppl 1 i29–38 [Article] [PubMed]
Creeley, CE, Dikranian, KT, Dissen, GA, Back, SA, Olney, JW, Brambrink, AM Isoflurane-induced apoptosis of neurons and oligodendrocytes in the fetal rhesus macaque brain.. Anesthesiology. (2014). 120 626–38 [Article] [PubMed]
Briner, A, De Roo, M, Dayer, A, Muller, D, Habre, W, Vutskits, L Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis.. Anesthesiology. (2010). 112 546–56 [Article] [PubMed]
Briner, A, Nikonenko, I, De Roo, M, Dayer, A, Muller, D, Vutskits, L Developmental stage-dependent persistent impact of propofol anesthesia on dendritic spines in the rat medial prefrontal cortex.. Anesthesiology. (2011). 115 282–93 [Article] [PubMed]
Qiu, L, Zhu, C, Bodogan, T, Gómez-Galán, M, Zhang, Y, Zhou, K, Li, T, Xu, G, Blomgren, K, Eriksson, LI, Vutskits, L, Terrando, N Acute and long-term effects of brief sevoflurane anesthesia during the early postnatal period in rats.. Toxicol Sci. (2016). 149 121–33 [Article] [PubMed]
De Roo, M, Klauser, P, Briner, A, Nikonenko, I, Mendez, P, Dayer, A, Kiss, JZ, Muller, D, Vutskits, L Anesthetics rapidly promote synaptogenesis during a critical period of brain development.. PLoS One. (2009). 4 e7043 [Article] [PubMed]
Yang, G, Chang, PC, Bekker, A, Blanck, TJ, Gan, WB Transient effects of anesthetics on dendritic spines and filopodia in the living mouse cortex.. Anesthesiology. (2011). 115 718–26 [Article] [PubMed]
Hansen, TG Anesthesia-related neurotoxicity and the developing animal brain is not a significant problem in children.. Paediatr Anaesth. (2015). 25 65–72 [Article] [PubMed]
Lei, SY, Hache, M, Loepke, AW Clinical research into anesthetic neurotoxicity: Does anesthesia cause neurological abnormalities in humans?. J Neurosurg Anesthesiol. (2014). 26 349–57 [Article] [PubMed]
Graham, MR, Brownell, M, Chateau, DG, Dragan, RD, Burchill, C, Fransoo, RR Neurodevelopmental assessment in kindergarten in children exposed to general anesthesia before the age of 4 years: A retrospective matched cohort study.. Anesthesiology. (2016). 125 667–77 [Article] [PubMed]
Davidson, AJ, Disma, N, de Graaff, JC, Withington, DE, Dorris, L, Bell, G, Stargatt, R, Bellinger, DC, Schuster, T, Arnup, SJ, Hardy, P, Hunt, RW, Takagi, MJ, Giribaldi, G, Hartmann, PL, Salvo, I, Morton, NS, von Ungern Sternberg, BS, Locatelli, BG, Wilton, N, Lynn, A, Thomas, JJ, Polaner, D, Bagshaw, O, Szmuk, P, Absalom, AR, Frawley, G, Berde, C, Ormond, GD, Marmor, J, McCann, ME GAS Consortium, Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): An international multicentre, randomised controlled trial.. Lancet. (2016). 387 239–50 [Article] [PubMed]
Gleich, SJ, Flick, R, Hu, D, Zaccariello, MJ, Colligan, RC, Katusic, SK, Schroeder, DR, Hanson, A, Buenvenida, S, Wilder, RT, Sprung, J, Voigt, RG, Paule, MG, Chelonis, JJ, Warner, DO Neurodevelopment of children exposed to anesthesia: Design of the Mayo Anesthesia Safety in Kids (MASK) study.. Contemp Clin Trials. (2015). 41 45–54 [Article] [PubMed]
Sun, LS, Li, G, Miller, TL, Salorio, C, Byrne, MW, Bellinger, DC, Ing, C, Park, R, Radcliffe, J, Hays, SR, DiMaggio, CJ, Cooper, TJ, Rauh, V, Maxwell, LG, Youn, A, McGowan, FX Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood.. JAMA. (2016). 315 2312–20 [Article] [PubMed]
Penzes, P, Cahill, ME, Jones, KA, VanLeeuwen, JE, Woolfrey, KM Dendritic spine pathology in neuropsychiatric disorders.. Nat Neurosci. (2011). 14 285–93 [Article] [PubMed]
Meredith, RM Sensitive and critical periods during neurotypical and aberrant neurodevelopment: A framework for neurodevelopmental disorders.. Neurosci Biobehav Rev. (2015). 50 180–8 [Article] [PubMed]
DiMaggio, C, Sun, LS, Li, G Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort.. Anesth Analg. (2011). 113 1143–51 [Article] [PubMed]
Ing, C, DiMaggio, C, Whitehouse, A, Hegarty, MK, Brady, J, von Ungern-Sternberg, BS, Davidson, A, Wood, AJ, Li, G, Sun, LS Long-term differences in language and cognitive function after childhood exposure to anesthesia.. Pediatrics. (2012). 130 e476–85 [Article] [PubMed]
Backeljauw, B, Holland, SK, Altaye, M, Loepke, AW Cognition and brain structure following early childhood surgery with anesthesia.. Pediatrics. (2015). 136 e1–12 [Article] [PubMed]
Li, Z, Okamoto, K, Hayashi, Y, Sheng, M The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.. Cell. (2004). 119 873–87 [Article] [PubMed]
Lotz, C, Zhang, J, Fang, C, Liem, D, Ping, P Isoflurane protects the myocardium against ischemic injury via the preservation of mitochondrial respiration and its supramolecular organization.. Anesth Analg. (2015). 120 265–74 [Article] [PubMed]
Kim, MH, Choi, J, Yang, J, Chung, W, Kim, JH, Paik, SK, Kim, K, Han, S, Won, H, Bae, YS, Cho, SH, Seo, J, Bae, YC, Choi, SY, Kim, E Enhanced NMDA receptor-mediated synaptic transmission, enhanced long-term potentiation, and impaired learning and memory in mice lacking IRSp53.. J Neurosci. (2009). 29 1586–95 [Article] [PubMed]
Chung, W, Choi, SY, Lee, E, Park, H, Kang, J, Park, H, Choi, Y, Lee, D, Park, SG, Kim, R, Cho, YS, Choi, J, Kim, MH, Lee, JW, Lee, S, Rhim, I, Jung, MW, Kim, D, Bae, YC, Kim, E Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression.. Nat Neurosci. (2015). 18 435–43 [Article] [PubMed]
Choi, SY, Han, K, Cutforth, T, Chung, W, Park, H, Lee, D, Kim, R, Kim, MH, Choi, Y, Shen, K, Kim, E Mice lacking the synaptic adhesion molecule Neph2/Kirrel3 display moderate hyperactivity and defective novel object preference.. Front Cell Neurosci. (2015). 9 283 [PubMed]
Rogers, GW, Brand, MD, Petrosyan, S, Ashok, D, Elorza, AA, Ferrick, DA, Murphy, AN High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria.. PLoS One. (2011). 6 e21746 [Article] [PubMed]
Ryu, MJ, Kim, SJ, Kim, YK, Choi, MJ, Tadi, S, Lee, MH, Lee, SE, Chung, HK, Jung, SB, Kim, HJ, Jo, YS, Kim, KS, Lee, SH, Kim, JM, Kweon, GR, Park, KC, Lee, JU, Kong, YY, Lee, CH, Chung, J, Shong, M Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice.. PLoS Genet. (2013). 9 e1003356 [Article] [PubMed]
Festing, MF Design and statistical methods in studies using animal models of development.. ILAR J. (2006). 47 5–14 [Article] [PubMed]
Rothstein, S, Simkins, T, Nuñez, JL Response to neonatal anesthesia: Effect of sex on anatomical and behavioral outcome.. Neuroscience. (2008). 152 959–69 [Article] [PubMed]
Morgan, MA, Pfaff, DW Effects of estrogen on activity and fear-related behaviors in mice.. Horm Behav. (2001). 40 472–82 [Article] [PubMed]
Bhatt, DH, Zhang, S, Gan, WB Dendritic spine dynamics.. Annu Rev Physiol. (2009). 71 261–82 [Article] [PubMed]
Chen, JL, Villa, KL, Cha, JW, So, PT, Kubota, Y, Nedivi, E Clustered dynamics of inhibitory synapses and dendritic spines in the adult neocortex.. Neuron. (2012). 74 361–73 [Article] [PubMed]
Dewing, P, Shi, T, Horvath, S, Vilain, E Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation.. Brain Res Mol Brain Res. (2003). 118 82–90 [Article] [PubMed]
Werling, DM, Parikshak, NN, Geschwind, DH Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders.. Nat Commun. (2016). 7 10717 [Article] [PubMed]
Ing, CH, DiMaggio, CJ, Malacova, E, Whitehouse, AJ, Hegarty, MK, Feng, T, Brady, JE, von Ungern-Sternberg, BS, Davidson, AJ, Wall, MM, Wood, AJ, Li, G, Sun, LS Comparative analysis of outcome measures used in examining neurodevelopmental effects of early childhood anesthesia exposure.. Anesthesiology. (2014). 120 1319–32 [Article] [PubMed]
Wilder, RT, Flick, RP, Sprung, J, Katusic, SK, Barbaresi, WJ, Mickelson, C, Gleich, SJ, Schroeder, DR, Weaver, AL, Warner, DO Early exposure to anesthesia and learning disabilities in a population-based birth cohort.. Anesthesiology. (2009). 110 796–804 [Article] [PubMed]
Flick, RP, Katusic, SK, Colligan, RC, Wilder, RT, Voigt, RG, Olson, MD, Sprung, J, Weaver, AL, Schroeder, DR, Warner, DO Cognitive and behavioral outcomes after early exposure to anesthesia and surgery.. Pediatrics. (2011). 128 e1053–61 [Article] [PubMed]
Sanchez, V, Feinstein, SD, Lunardi, N, Joksovic, PM, Boscolo, A, Todorovic, SM, Jevtovic-Todorovic, V General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain.. Anesthesiology. (2011). 115 992–1002 [Article] [PubMed]
Boscolo, A, Milanovic, D, Starr, JA, Sanchez, V, Oklopcic, A, Moy, L, Ori C, C, Erisir, A, Jevtovic-Todorovic, V Early exposure to general anesthesia disturbs mitochondrial fission and fusion in the developing rat brain.. Anesthesiology. (2013). 118 1086–97 [Article] [PubMed]
Boscolo, A, Ori, C, Bennett, J, Wiltgen, B, Jevtovic-Todorovic, V Mitochondrial protectant pramipexole prevents sex-specific long-term cognitive impairment from early anaesthesia exposure in rats.. Br J Anaesth. (2013). 110Suppl 1 i47–52 [Article] [PubMed]
Boscolo, A, Starr, JA, Sanchez, V, Lunardi, N, DiGruccio, MR, Ori, C, Erisir, A, Trimmer, P, Bennett, J, Jevtovic-Todorovic, V The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: The importance of free oxygen radicals and mitochondrial integrity.. Neurobiol Dis. (2012). 45 1031–41 [Article] [PubMed]
Lemoine, S, Zhu, L, Gress, S, Gérard, JL, Allouche, S, Hanouz, JL Mitochondrial involvement in propofol-induced cardioprotection: An in vitro study in human myocardium.. Exp Biol Med (Maywood). (2016). 241 527–38 [Article] [PubMed]
Tsai, SY, Hayashi, T, Harvey, BK, Wang, Y, Wu, WW, Shen, RF, Zhang, Y, Becker, KG, Hoffer, BJ, Su, TP Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.. Proc Natl Acad Sci USA. (2009). 106 22468–73 [Article] [PubMed]
Wu, B, Yu, Z, You, S, Zheng, Y, Liu, J, Gao, Y, Lin, H, Lian, Q Physiological disturbance may contribute to neurodegeneration induced by isoflurane or sevoflurane in 14 day old rats.. PLoS One. (2014). 9 e84622 [Article] [PubMed]
Fridovich, I Oxygen toxicity: A radical explanation.. J Exp Biol. (1998). 201Pt 8 1203–9 [PubMed]
Fig. 1.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
Fig. 1.
Sevoflurane exposure in postnatal day (PND) 16 to 17 male mice transiently increases miniature excitatory postsynaptic current (mEPSC) frequency and decreases miniature inhibitory postsynaptic current (mIPSC) frequency in the medial prefrontal cortex (mPFC) layer II/III pyramidal neurons. (A) Examples of mEPSCs 6 h after sevoflurane or oxygen exposure. (B) Increased frequency but normal amplitude of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 16 cells from three mice for sevoflurane-exposed mice; *P < 0.05, Student’s t test). (C) Examples of mIPSCs 6 h after sevoflurane or oxygen exposure. (D) Decreased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 18 cells from four mice for control and n = 21 cells from four mice for sevoflurane-exposed mice; *P < 0.05, Welch t test). (E) Examples of mEPSCs 5 days after sevoflurane or oxygen exposure. (F) Normal frequency and amplitude of mEPSCs 5 days after sevoflurane exposure (n = 13 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (G) Examples of mIPSCs 5 days after sevoflurane or oxygen exposure. (H) Normal frequency and amplitude of mIPSCs 5 days after sevoflurane exposure (n = 14 cells from three mice for control and n = 15 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). Values are presented as mean ± SD. n.s. = not significant.
×
Fig. 2.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Fig. 2.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not increase the expression of neurodegeneration markers but increases the expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluA2. (A to D) Western blot was performed with cerebral cortex samples obtained after oxygen or sevoflurane exposure in a time-dependent manner (n = 3 to 4 for control and n = 4 to 5 for sevoflurane-exposed mice). (E) Quantification of the Western blot results of postsynaptic density 95 (PSD95) after sevoflurane exposure. (F) Quantification of the Western blot results of AMPA receptor subunit GluA1 after sevoflurane exposure. (G) Quantification of the Western blot results of AMPA receptor subunit GluA2 after sevoflurane exposure. Values are presented as mean ± SD. *P < 0.0125, Welch or independent Student’s t test; Bonferroni correction. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
×
Fig. 3.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
Fig. 3.
Sevoflurane exposure in postnatal day (PND) 16 to 17 mice does not induce long-term behavioral abnormalities. (A, B) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (n = 16 for both groups; independent Student’s t test). (C) Sevoflurane-exposed mice spend a comparable time in the light compartment of the light-dark box test (n = 16 for both groups; independent Student’s t test). (D) Sevoflurane-exposed mice spend a comparable time in the open arms of the elevated plus maze (n = 20 for control and 17 for sevoflurane exposure; independent Student’s t test). (E to G) Sevoflurane exposure did not affect sociability in the three-chamber test. (E) Representative heat map images of the three-chamber test. (F, G) Quantification of the results in the three-chamber test (n = 16 for both groups; independent Student’s t test). (H) Sevoflurane-exposed mice displayed similar levels of memory in the novel object recognition test (n = 20 for control and 17 for sevoflurane exposure; Kruskal–Wallis test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (n = 16 for both groups; linear mixed effect modeling with a fixed effect for slope and group. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (n = 16 for both groups; independent Student’s t test and Welch t test). Values are presented as mean ± SD. n.s. = not significant.
×
Fig. 4.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
Fig. 4.
Sevoflurane exposures in postnatal day (PND) 16 to 17 mice affect the function of mitochondria and mass of oxidative phosphorylation (OXPHOS) complex from cortex region. (A to H) Oxygen consumption rates (OCR) were measured from isolated mitochondria in the cerebral cortex in a time-dependent manner in five different conditions. I: basal OCR, II: basal OCR with adenosine diphosphate for adenosine triphosphate (ATP) generation and proton flow, III: ATP production and proton leak rate with oligomycin, IV: maximal OCR with carbonyl cyanide m-chlorophenyl hydrazine (CCCP), V: nonmitochondrial OCR with antimycin A. Basal measurements were compared with Welch or independent Student’s t test. Changes of OCR were compared by linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model. Bonferroni correction was used. (A, B) OCR was measured immediately after sevoflurane exposure (n = 5 mice were used in both groups; *P < 0.05). (C, D) OCR was measured 3 h after sevoflurane exposure (n = 5 mice in control and n = 6 for sevoflurane-exposed mice; *P < 0.017). (E, F) OCR was measured 6 h after sevoflurane exposure (n = 6 mice in control and n = 6 for sevoflurane-exposed mice). (G, H) OCR was measured 9 h after sevoflurane exposure (n = 8 mice for both control and sevoflurane exposure; *P < 0.05 for basal measurements and *P < 0.017 for slope changes). (I, J) Expression of the mitochondrial OXPHOS complex I subunit NDUFB8 was analyzed in a time-dependent manner with Western blot. Band intensity was calculated with Image J and presented in (I) (n = 4 for control and n = 4 or 5 for sevoflurane-exposed mice; *P < 0.0125; Welch or independent Student’s t test; Bonferroni correction was used). Values are presented as mean ± SD. n.s. = not significant.
×
Fig. 5.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
Fig. 5.
Sevoflurane exposure in postnatal day (PND) 16 to 17 female mice increases excitatory synaptic protein expression and inhibitory synaptic transmission but does not affect adult behavior. (A) Examples of miniature excitatory postsynaptic currents (mEPSCs) 6 h after sevoflurane or oxygen exposure. (B) Normal amplitude and frequency of mEPSCs 6 h after sevoflurane exposure (n = 15 cells from three mice for control and n = 17 cells from three mice for sevoflurane-exposed mice; independent Student’s t test). (C) Western blot was performed with cerebral cortex samples obtained 6 h after oxygen or sevoflurane exposure. (D) Western blot quantification results of postsynaptic density 95 (PSD95), AMPA receptor subunit GluA1, AMPA receptor subunit GluA2 after sevoflurane exposure (n = 4 for control and n = 5 for sevoflurane-exposed mice; *P < 0.05 and **P < 0.01, independent Student’s t test). (E) Examples of miniature inhibitory synaptic currents (mIPSCs) 6 h after sevoflurane or oxygen exposure. (F) Increased frequency but normal amplitude of mIPSCs 6 h after sevoflurane exposure (n = 10 cells from three mice for control and n = 12 cells from three mice for sevoflurane-exposed mice; *P < 0.05, independent Student’s t test). (G, H) Sevoflurane-exposed mice exhibit normal activity and spend a comparable amount of time in the center region in the open field test (independent Student’s t test). (I) Sevoflurane exposure did not affect female sociability in the three-chamber test (independent Student’s t test). (I to K) Sevoflurane exposure did not affect learning and memory in the fear chamber test. (I) The conditioning slope was not effected by sevoflurane exposure (linear mixed effect modeling with a fixed effect for slope. Correlated random intercept and random slope term were incorporated into the model). (J, K) Mice exposed to sevoflurane displayed comparable contextual- and cued-fear test performance (independent Student’s t test and Kruskal–Wallis test). The number of mice used in behavioral tests: n = 15 for control and n = 17 for sevoflurane-exposed mice. Values are presented as mean ± SD. n.s. = not significant; PARP = poly (adenosine diphosphate-ribose) polymerase.
×
Table 1.
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia×
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Table 1.
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia
Arterial Blood Gas Analysis of Mice after Sevoflurane Anesthesia×
×